Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Carpenter, John Paul ^a,b   Alpendurada, Francisco ^a   Deac, Monica ^a   MacEira, Alicia ^c   Garbowski, MacIej ^d   Kirk, Paul ^a,b   Walker, J Malcolm ^d   Porter, John ^d   Shah, Farrukh ^e   Banya, Winston ^a   He, Taigang ^a   Smith, Gillian ^a,b   Pennell, Dudley ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c Hospital General Universitario Avda   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; HEMOGLOBIN; IRON; IRON CHELATING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INDEX; HEART MUSCLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE VOLUME; HUMAN; IRON OVERLOAD; MALE; PARAMETER; PRIORITY JOURNAL; THALASSEMIA MAJOR; BETA THALASSEMIA; BLOOD TRANSFUSION; CASE CONTROL STUDY; HEART STROKE VOLUME; HEART VENTRICLE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; REFERENCE VALUE; RETROSPECTIVE STUDY;

ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; DEFEROXAMINE; FEMALE; HEART VENTRICLES; HEMOGLOBINS; HUMANS; IRON; IRON CHELATING AGENTS; MAGNETIC RESONANCE IMAGING, CINE; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 77954595872     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-24     Document Type: Article

References (35)

1. Weatherall DJ Clegg JB, The thalassaemia syndromes Blackwell Science 2001 ISBN 0-86542-664-3
2. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Borgna-Pignatti C Rugolotto S, De Stefano P Zhao H, Cappellini MD Del Vecchio GC, Romeo MA Forni GL, Gamberini MR Ghilardi R, Piga A Cnaan A, Haematologica 2004 89 1187 93 15477202
3. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Modell B Khan M, Darlison M Westwood MA, Ingram D Pennell DJ, J Cardiovasc Magn Reson 2008 10 42 10.1186/1532-429X-10-42 18817553
4. Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. Westwood MA Anderson LJ Maceira AM Shah FT, Prescott E Porter JB, Wonke B Walker JM, Pennell DJ,, J Magn Reson Imaging 2007 25 1147 1151 10.1002/jmri.20915 17520718
5. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. Maceira AM Prasad SK, Khan M Pennell DJ, J Cardiovasc Magn Reson 2006 8 417 426 10.1080/ 10976640600572889 16755827
6. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. Felker GM Thompson RE, Hare JM Hruban RH, Clemetson DE Howard DL, Baughman KL Kasper EK, N Engl J Med 2000 342 1077 1084 10.1056/NEJM200004133421502 10760308
7. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Anderson LJ Holden S Davis B Prescott E, Charrier CC Bunce NH, Firmin DN Wonke B, Porter J Walker JM, Pennell DJ,, Eur Heart J 2001 23 2171 2179 10.1053/euhj.2001.2822
8. Impact of myocardial iron loading on right ventricular function [abstract]. Alpendurada F Deac M Carpenter JP Kirk P, Pennell DJ,, J Cardiovasc Magn Reson 2009 11 Suppl I 162 10.1186/1532-429X-11-S1-P162
9. Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Grothues F Moon JC, Bellenger NG Smith GS, Klein HU Pennell DJ, Am Heart J 2004 147 218 223 10.1016/j.ahj.2003. 10.005 14760316
10. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F Smith GC Moon JCC Bellenger NG, Collins P Klein HU, Pennell DJ,, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775
11. Reduction in sample size for studies of remodelling in heart failure by the use of cardiovascular magnetic resonance. Bellenger NG Davies LC Francis JM Coats AJS, Pennell DJ,, J Cardiovasc Magn Reson 2000 2 271 278 10.3109/10976640009148691 11545126
12. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Maceira AM Prasad SK, Khan M Pennell DJ, Eur Heart J 2006 27 2879 2888 10.1093/eurheartj/ehl336 17088316
13. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. Westwood M Anderson LJ Firmin DN Gatehouse PD, Charrier CC Wonke B, Pennell DJ,, J Magn Reson Imaging 2003 18 33 39 10.1002/jmri.10332 12815637
14. Ventricular function. Bellenger NG Pennell DJ, Cardiovascular magnetic resonance New York, NY: Churchill Livingstone, Manning WJ, Pennell DJ, 2002 99 111
15. Simplified calculation of body surface area. Mosteller RD, N Engl J Med 1987 317 1098 3657876
16. Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. He T Gatehouse PD, Smith GC Mohiaddin RH, Pennell DJ Firmin DN, Magn Reson Med 2008 60 1082 1089 10.1002/mrm.21744 18956471
17. Survival in beta thalassaemia major in the UK: data from the UK thalassaemia register. Modell B Khan M Darlison M,, Lancet 2000 355 2051 2052 10.1016/S0140-6736(00)02357-6 10885361
18. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Kirk P Roughton M Porter JB Walker JM, Tanner MA Patel J, Wu D Taylor J, Westwood MA Anderson LJ, Pennell DJ,, Circulation 2009 120 1961 1968 10.1161/CIRCULATIONAHA.109.874487 19801505
19. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Davis BA O'Sullivan C, Jarritt PH Porter JB, Blood 2004 104 263 269 10.1182/blood-2003-08-2841 15001468
20. Standards for the clinical care of children and adults with thalassaemia in the UK. The UK Thalassaemia Society 2005 ISBN 1 900254 18 2
21. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. La Vecchia L Zanolla L Varotto L Bonanno C, Spadaro GL Ometto R, Fontanelli A,, Am Heart J 2001 142 181 189 10.1067/mhj.2001.116071 11431676
22. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Meyer P Filippatos GS, Ahmed MI Iskandrian AE, Bittner V Gilbert J, Perry GJ White M, Aban IB Mujib M, Dell'Italia LJ Ahmed A, Circulation 2010 121 252 258 10.1161/CIRCULATIONAHA.109.887570 20048206
23. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. Di Salvo TG Mathier M, Semigran MJ Dec GW, J Am Coll Cardiol 1995 25 1143 1153 10.1016/0735-1097(94)00511-N 7897128
24. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. de Groote P Millaire A Foucher-Hossein C Nugue O, Marchandise X Ducloux G, Lablanche JM,, J Am Coll Cardiol 1998 32 948 954 10.1016/S0735-1097(98)00337-4 9768716
25. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. Ghio S Gavazzi A Campana C Inserra C, Klersy C Sebastiani R, Arbustini E Recusani F, Tavazzi L,, J Am Coll Cardiol 2001 37 183 188 10.1016/S0735-1097(00) 01102-5 11153735
26. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Roos-Hesselink JW Meijboom FJ, Spitaels SE van Domburg R, van Rijen EH Utens EM, McGhie J Bos E, Bogers AJ Simoons ML, Eur Heart J 2004 25 1264 1270 10.1016/j.ehj.2004.03.009 15246646
27. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. Graham TP Jr Bernard YD Mellen BG Celermajer D, Baumgartner H Cetta F, Connolly HM Davidson WR, Dellborg M Foster E, Gersony WM Gessner IH, Hurwitz RA Kaemmerer H, Kugler JD Murphy DJ, Noonan JA Morris C, Perloff JK Sanders SP, Sutherland JL,, J Am Coll Cardiol 2000 36 255 261 10.1016/S0735-1097(00)00682-3 10898443
28. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Gatzoulis MA Clark AL Cullen S Newman CG, Redington AN,, Circulation 1995 91 1775 1781 7882487
29. Pulmonary hypertension in beta-thalassemia. Aessopos A Farmakis D, Ann N Y Acad Sci 2005 1054 342 349 10.1196/annals.1345.041 16339682
30. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Aessopos A Farmakis D Deftereos S Tsironi M, Tassiopoulos S Moyssakis I, Karagiorga M,, Chest 2005 127 1523 1530 10.1378/chest.127.5.1523 15888823
31. Cardiac status in well-treated patients with thalassemia major. Aessopos A Farmakis D, Hatziliami A Fragodimitri C, Karabatsos F Joussef J, Mitilineou E Diamanti-Kandaraki E, Meletis J Karagiorga M, Eur J Haematol 2004 73 359 366 10.1111/j.1600-0609.2004.00304.x 15458515
32. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Saba TS Foster J Cockburn M Cowan M, Peacock AJ,, Eur Respir J 2002 20 1519 1524 10.1183/09031936.02.00014602 12503713
33. Right ventricular cardiomyopathy in beta-thalassaemia major. Hahalis G Manolis AS, Apostolopoulos D Alexopoulos D, Vagenakis AG Zoumbos NC, Eur Heart J 2002 23 147 156 10.1053/euhj.2001.2709 11785997
34. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Mavrogeni S Gotsis E Ladis V Berdousis E, Verganelakis D Toulas P, Cokkinos DV,, Int J Cardiovasc Imaging 2008 24 849 854 10.1007/s10554-008-9332-2 18581254
35. Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*. Pepe A Lombardi M, Positano V Cracolici E, Capra M Malizia R, Prossomariti L De Marchi D, Midiri M Maggio A, Eur J Haematol 2006 76 183 192 10.1111/j.1600-0609.2005.00587.x 16451393